Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DRUG | US
-9.69
-25.18%
Healthcare
Biotechnology
30/06/2024
16/10/2024
28.80
27.63
36.00
21.50
Bright Minds Biosciences Inc. a biotechnology company develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C 5-HT2A and 5-HT2C/A for the treatment of epilepsy pain and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York New York.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
7232.0%1 month
4900.2%3 months
2879.5%6 months
2053.9%-
-
1.08
0.00
0.00
-0.07
-
-
-
142.02M
142.02M
-
-
-
-
-51.80
3.50
2.38
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
37.55
Range1M
37.55
Range3M
37.55
Rel. volume
2.16
Price X volume
390.03M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Centrexion Therapeutics Corporation | CNTX | Biotechnology | 2.05 | 153.75M | 5.13% | n/a | 0.00% |
Compugen Ltd | CGEN | Biotechnology | 1.7 | 152.21M | 4.29% | n/a | 5.19% |
Repare Therapeutics Inc | RPTX | Biotechnology | 3.42 | 151.17M | 1.79% | n/a | 1.07% |
Inovio Pharmaceuticals Inc | INO | Biotechnology | 5.74 | 149.04M | 2.87% | n/a | 13.42% |
Acumen Pharmaceuticals Inc. Common Stock | ABOS | Biotechnology | 2.39 | 143.59M | 2.58% | n/a | 11.57% |
Seres Therapeutics Inc | MCRB | Biotechnology | 0.8426 | 143.41M | 3.32% | n/a | -244.19% |
Rani Therapeutics Holdings Inc. Class A Common Stock | RANI | Biotechnology | 2.6 | 142.14M | 22.64% | n/a | 1243.32% |
Puma Biotechnology Inc | PBYI | Biotechnology | 2.88 | 141.25M | 1.05% | 15.00 | 203.23% |
Tenaya Therapeutics Inc. Common Stock | TNYA | Biotechnology | 1.75 | 138.06M | 3.55% | n/a | 11.62% |
Century Therapeutics Inc. Common Stock | IPSC | Biotechnology | 1.57 | 133.00M | 4.67% | n/a | 25.38% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 8 | 148.91M | 18.69% | n/a | 58.43% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 32.49 | 93.31M | 1.12% | 5.27 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14.34 | 89.79M | -0.14% | 14.47 | 7.10% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.5 | 19.04M | 4.17% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.02 | 18.42M | 2.01% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.6542 | 9.49M | -5.19% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2051 | 3.68M | -6.82% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.09 | 2.84M | -0.91% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -0.99% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.42 | 0 | 2.63% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.07 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 1.08 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 2,879.53 | 72.92 | Riskier |
Debt to Equity | 0.00 | -1.24 | Expensive |
Debt to Assets | 0.00 | 0.25 | Cheaper |
Market Cap | 142.02M | 3.78B | Emerging |